Reference
Nabitaka VM, et al. High acceptability and viral suppression of patients on Dolutegravir-based first-line regimens in pilot sites in Uganda: A mixed methods prospective cohort study. PLOS One 15: No. 5, May 2020. Available from: URL: http://doi.org/10.1371/journal.pone.0232419
Rights and permissions
About this article
Cite this article
Antiretrovirals. Reactions Weekly 1812, 42 (2020). https://doi.org/10.1007/s40278-020-80521-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-80521-9